Giulio Fracasso

14PUBLICATIONS
52CO-AUTHORS
Radiation therapyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 11, 2024
Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer.

Cristina Bolzati, Carolina Gobbi, Guillermina Ferro-Flores

|Jun 28, 2023
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children.

Alessia Dallatana, Linda Cremonesi, Maddalena Trombetta

|Mar 15, 2023
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy.

Stefania Canè, Roza Maria Barouni, Marina Fabbi

|Feb 09, 2023
D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer.

Monira Sarkis, Georges Minassian, Nadim Mitri

|Apr 13, 2022
Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles.

Nadim Mitri, Kamil Rahme, Giulio Fracasso

|Nov 27, 2021
Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model.

Giamaica Conti, Martina Pitea, Riccardo Ossanna

Pageof 3

Frequent Collaborators

2 joint publications

Nadim Mitri

2 joint publications

Aldo Scarpa

2 joint publications

Esther Ghanem

2 joint publications

Pierpaolo Ceci